An observational study in Type 2 DM, sponsored by Zeng Lin, Ph. D.. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-12-05.
Sponsored by Zeng Lin, Ph. D. · Observational
This study will be conducted from enrollment until the end of the six-month follow-up period.
This study aims to assess the impact of the Internet hospital online + offline integrated chronic disease management model on patients with type 2 diabetes mellitus. It will also evaluate the economic impact of the model and identify the characteristics of the appropriate population for the model. Finally, it will develop a toolkit to help manage chronic diseases.
The study will include 1,636 patients with type 2 diabetes who did not reach the standard of control target of glucose, blood pressure or LDL at the endocrine outpatient clinic and inpatient wards of the Third Hospital of Peking University. We will collect information from participants before the study starts. And the patients will be followed up for 6 months from enrollment. The study management mode included online and offline integrated management in the Internet hospital, and routine offline management mode. After completing the enrollment and assessment, we will arrange outpatient follow-up and management according to the current status, doctor's requirements, and study subjects' needs.
990 studies on the registry are indexed under Chronic Disease; 178 are open to participants now.
This study's planned enrollment of 1,636 is above the median of 419 across 249 observational studies indexed under Chronic Disease.
Browse Chronic Disease studies →This is the only study on the registry with Zeng Lin, Ph. D. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
The study will include patients with type 2 diabetes who did not meet the control target of glucose, blood presure or LDL at the endocrine outpatient clinic and inpatient wards of the Third Hospital of Peking University.
Exclusion Criteria:
the proportion of patients achieved all three targets (HbA1c < 7.0%, blood pressure < 130/80 mmHg and LDL-cholesterol < 2.6 mmol/L)
Time frame: at 6±1 month from the enrollment
patient adherence using 8-item Morisky Medication Adherence Scale (MMAS-8)
Time frame: at 3±1 month from the enrollment
patient satisfaction using Visual Analogue Scale (VAS)
Time frame: at 3±1 month from the enrollment
Hypoglycemic events
Time frame: at 3±1 month from the enrollment
Acute complications
Time frame: at 3±1 month from the enrollment
Hospitalization for any reason
Time frame: at 3±1 month from the enrollment
blood glucose level
Time frame: at 3±1 month from the enrollment
blood pressure assessment
Time frame: at 3±1 month from the enrollment
Laboratory tests for blood lipid level (Low Density Lipoprotein-Cholesterol, LDL-C)
Time frame: at 3±1 month from the enrollment
patient adherence using 8-item Morisky Medication Adherence Scale (MMAS-8)
Time frame: at 6±1 month from the enrollment
patient satisfaction using Visual Analogue Scale (VAS)
Time frame: at 6±1 month from the enrollment
blood glucose level
Time frame: at 6±1 month from the enrollment
blood pressure assessment
Time frame: at 6±1 month from the enrollment
diabetes self-management ability using Summary of Diabetes Self-Care Activities Questionnaire (C-SDSCA)
Time frame: at 6±1 month from the enrollment
diabetes self-management ability using Confidence in Diabetes Management Self-Efficacy Scale (C-DMSES)
Time frame: at 6±1 month from the enrollment
Direct Medical Cost
Time frame: at 6±1 month from the enrollment
Laboratory tests for blood lipid level (Total Cholesterol, TC)
Time frame: at 6±1 month from the enrollment
Laboratory tests for blood lipid level (Triglycerides, TG)
Time frame: at 6±1 month from the enrollment
Laboratory tests for blood lipid level (Low Density Lipoprotein-Cholesterol, LDL-C)
Time frame: at 6±1 month from the enrollment
Laboratory tests for blood lipid level (High Density Lipoprotein-Cholesterol, HDL-C)
Time frame: at 6±1 month from the enrollment
Hypoglycemic events
Time frame: at 6±1 month from the enrollment
Acute complications
Time frame: at 6±1 month from the enrollment
Hospitalization for any reason
Time frame: at 6±1 month from the enrollment
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.